Genetic Technologies (GENE) Institutional Ownership $0.76 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Genetic Technologies (NASDAQ:GENE)CurrentInstitutional OwnershipPercentage0.63%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$236.30KNumber ofInstitutional Sellers(last 12 months)0 Get GENE Insider Trade Alerts Want to know when executives and insiders are buying or selling Genetic Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GENE Institutional Buying and Selling by Quarter Genetic Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC140,000$210K0.0%N/A3.177% 5/1/2024BNP Paribas Financial Markets9,100$26K0.0%N/A0.236% 11/7/2023Scarborough Advisors LLC548,372$417K0.0%+5,054.8%2.850% 3/6/2023OLD Mission Capital LLC70,241$65K0.0%+109.7%0.365% 11/22/2022Continental Investors Services Inc.32,000$47K0.0%N/A0.208% 11/14/2022OLD Mission Capital LLC33,499$39K0.0%N/A0.218% 8/13/2021Jump Financial LLC10,657$45K0.0%N/A0.069% 8/11/2021Susquehanna Fundamental Investments LLC36,172$154K0.0%-44.0%0.235% 5/17/2021 Hennion & Walsh Asset Management Inc.10,072$42K0.0%N/A0.067% 5/17/2021Goldman Sachs Group Inc.21,602$90K0.0%N/A0.144% 2/12/2021Credit Suisse AG20,836$75K0.0%N/A0.139% 11/13/2020Morgan Stanley10,447$36K0.0%+109.1%0.077% (Data available from 1/1/2016 forward) GENE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GENE shares? During the previous two years, the following institutional investors and hedge funds held shares of Genetic Technologies shares: Scarborough Advisors LLC ($417K), Armistice Capital LLC ($210K), and OLD Mission Capital LLC ($65K), BNP Paribas Financial Markets ($26K).Learn more on GENE's institutional investors. What percentage of Genetic Technologies stock is owned by institutional investors? 0.63% of Genetic Technologies stock is owned by institutional investors. Learn more on GENE's institutional investor holdings. Which institutional investors have been buying Genetic Technologies stock? The following institutional investors have purchased Genetic Technologies stock in the last 24 months: Scarborough Advisors LLC ($537.73K), Armistice Capital LLC ($140K), OLD Mission Capital LLC ($36.74K), and BNP Paribas Financial Markets ($9.10K). How much institutional buying is happening at Genetic Technologies? Institutional investors have bought a total of 723,576 shares in the last 24 months. This purchase volume represents approximately $2.46M in transactions. Related Companies SNSE Major Shareholders CRVO Major Shareholders TXMD Major Shareholders BMRA Major Shareholders KPRX Major Shareholders CLDI Major Shareholders PMCB Major Shareholders CHRO Major Shareholders TLPH Major Shareholders RLMD Major Shareholders This page (NASDAQ:GENE) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTexas embraces new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
